Sweden· SE-20210715000026
Glycopyrronium Cantabria 2,2 mg/pumpning Kräm
A glycopyrronium product containing glycopyrronium, registered in Sweden by Industrial Farmaceutica Cantabria S.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium is registered in 14 of 19 countries.
Countries holding a registration under ATC D11AA01 (glycopyrronium), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 8 of them publish a price we can compare per daily dose
Glycopyrronium · ATC D11AA01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Glycopyrronium
- Manufacturer
- Industrial Farmaceutica Cantabria S.A.
- Country
- Sweden (SE)
- ATC code
- D11AA01
- ATC class
- Glycopyrronium
- Defined daily dose
- 8.8 mg, T
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20210715000026
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
108 interactions on record for glycopyrronium.
Graded by severity as the source publishes them — 107 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glycopyrronium · interactions on record
108 records
- 107 moderate
- 1 minor
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glycopyrronium in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAxhidrox 2,2 mg/Hub, CremeGebro Pharma AG
- SpainAXHIDROX 2,2 MG/PULSACION CREMAIndustrial Farmaceutica Cantabria S.A.
- PolandAxhidroxDr. August Wolff GmbH & Co. KG Arzneimittel
- NetherlandsAxhidrox 8 mg/g, crèmeEuro Registratie Collectief B.V.
- ItalyGLICOPIRRONIO DOCDOC GENERICI S.R.L.
- IcelandEnurev BreezhalerNovartis Europharm Limited*
- United StatesQbrexzaJourney Medical Corporation
- GermanyRybrilaColonis Pharma B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Austria · Rybrila
- Germany · Rybrila
- Spain · Axhidrox
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15654dcf-b4e3-4730-a151-ed7c8824e601 GET /v1/drugs/15654dcf-b4e3-4730-a151-ed7c8824e601?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"sRMP",
"sPAR",
"SmPC",
"PL",
"PAR"
],
"se_npl_id": "20210715000026",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20210715000026",
"product_doc_link": "https://docetp.mpa.se/LMF/Glycopyrronium%20Cantabria%20cream%20ENG%20SmPC_09001bee82aa251f.pdf"
}See everything about glycopyrronium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.